Corneal Injury
Gene therapy suppresses neovascularization to improve ocular environment
Published in Gene Therapy Weekly, October 3rd, 2002
In a collaborative study carried out by investigators from the United States and Ireland, interleukin (IL)-1 receptor antagonist (IL-1 RA) gene therapy was used to stem corneal neovascularization and change inflammatory cytokine profiles in conjunctivalized cornea murine models.
Animals were subjected to corneal injury just before receiving therapy. "Total corneal epithelial and limbal debridement was performed with a combination of alkali and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-10-03)
More Articles from Gene Therapy Weekly
- Liver Grafting
Therapy smoothes way for reperfusion in steatotic liver transplantation - Pancreatic Cancer
Bax gene therapy promotes apoptosis in pancreatic cancer cells - Cell Biology
Targeting enzymes that immortalize cancer cells: If they can't be turned off, try to round them up - Hemophilia B
Human blood clotting factor achieves sustained levels in rhesus macaques - Neonatology
Bone marrow cells may contribute to growth of new blood vessels in newborns - Bladder Cancer
Antisense technology may help reverse cisplatin-resistance - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
